We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$155B
AUM Growth
+$5.59B
Cap. Flow
-$1.23B
Cap. Flow %
-0.8%
Top 10 Hldgs %
15.41%
Holding
3,924
New
119
Increased
2,245
Reduced
1,145
Closed
87

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$128M
2
AAL icon
American Airlines Group
AAL
+$99.2M
3
NAVI icon
Navient
NAVI
+$54.9M
4
ESS icon
Essex Property Trust
ESS
+$53.7M
5
AVGO icon
Broadcom
AVGO
+$47.2M

Sector Composition

Rank Sector Weight
1 Financials 14.61%
2 Technology 13.94%
3 Healthcare 13.29%
4 Industrials 10.85%
5 Energy 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOA
3376
DELISTED
BioAmber Inc.
BIOA
$260K ﹤0.01%
+26,174
New +$270K
ORC
3377
Orchid Island Capital
ORC
$1.29B
$258K ﹤0.01%
3,951
ALXA
3378
DELISTED
Alexza Pharmaceuticals Inc
ALXA
$258K ﹤0.01%
56,488
+4,040
+8% +$17.4K
SYPR icon
3379
Sypris Solutions
SYPR
$47.4M
$257K ﹤0.01%
46,115
+7,023
+18% +$28.9K
TOVX icon
3380
Theriva Biologics
TOVX
$10.2M
$256K ﹤0.01%
17
MERU
3381
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
$256K ﹤0.01%
69,639
-126
-0.2% -$497
VSB
3382
DELISTED
VANTAGESOUTH BANCHARES, INC
VSB
$254K ﹤0.01%
42,750
+24,378
+133% +$150K
HIVE
3383
DELISTED
Aerohive Networks
HIVE
$253K ﹤0.01%
+30,808
New +$300K
STXS icon
3384
Stereotaxis
STXS
$141M
$252K ﹤0.01%
88,760
-18
-0% -$54
FALC
3385
DELISTED
FalconStor Software Inc
FALC
$250K ﹤0.01%
147,095
-169
-0.1% -$267
SWSH
3386
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
$250K ﹤0.01%
58,150
-5,426
-9% -$21.6K
GNSS icon
3387
Genasys
GNSS
$77M
$249K ﹤0.01%
121,112
ACG
3388
DELISTED
AllianceBernstein Income Fund Inc
ACG
0
RCMT icon
3389
RCM Technologies
RCMT
$204M
$248K ﹤0.01%
39,064
GKNT
3390
DELISTED
GEEKNET INC COM NEW
GKNT
$248K ﹤0.01%
19,957
-21
-0.1% -$287
SONY icon
3391
Sony
SONY
$140B
$247K ﹤0.01%
73,840
-6,050
-8% -$20.9K
ORM
3392
DELISTED
Owens Realty Mortgage, Inc.
ORM
$247K ﹤0.01%
+12,729
New +$216K
CALL
3393
DELISTED
magicJack VocalTec Ltd
CALL
$247K ﹤0.01%
16,401
+70
+0.4% +$1.18K
KYO
3394
DELISTED
Kyocera Adr
KYO
$247K ﹤0.01%
+5,211
New +$239K
ALT icon
3395
Altimmune
ALT
$583M
$245K ﹤0.01%
581
CCUR
3396
DELISTED
CCUR Holdings, Inc. Common Stock
CCUR
$245K ﹤0.01%
32,962
-24
-0.1% -$193
IMUC
3397
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$245K ﹤0.01%
5,476
ACHV icon
3398
Achieve Life Sciences
ACHV
$689M
$243K ﹤0.01%
30
-4
-12% -$49.1K
INOD icon
3399
Innodata
INOD
$2.09B
$243K ﹤0.01%
75,619
-84
-0.1% -$255
STRM
3400
DELISTED
Streamline Health Solutions
STRM
$243K ﹤0.01%
3,389

Similar funds

Geode Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Geode Capital Management held 3,924 positions worth $155B, up 3.7% from $149B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management's Q2 2014 filing shows 119 new, 2,245 increased, 1,145 reduced and 87 closed positions. Its largest new stake was Navient: 3,319,977 shares worth $58.8M. The largest sale was Apple, an estimated $219M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

  • Geode Capital Management's largest Q2 2014 buy was Navient: 3,319,977 shares worth $58.8M.
  • Geode Capital Management added most to Allergan plc in Q2 2014, an estimated $128M increase.
  • Geode Capital Management's biggest Q2 2014 reduction was Apple, cutting an estimated $219M.
  • Geode Capital Management fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $103M.
  • Geode Capital Management's ten largest holdings make up 15% of its $155B portfolio in Q2 2014.
  • Geode Capital Management opened 119 new positions and closed 87 in Q2 2014.
  • Geode Capital Management's portfolio value rose 3.7% quarter-over-quarter to $155B.

Based on Geode Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.